Besifloxacin

Sharing is caring!

Besifloxacin Brand Name– Besivance

What is Besifloxacin

Besifloxacin is a fluoroquinolone ophthalmic suspension indicated for the treatment of bacterial conjunctivitis.

Besifloxacin was approved by the FDA in April 2009.

Indications

  1. Aerococcus viridans
  2. bacterial conjunctivitis
  3. CDC coryneform group G
  4. Corynebacterium pseudodiphtheriticum
  5. Corynebacterium striatum
  6. Haemophilus influenzae (beta-lactamase negative)
  7. Haemophilus influenzae (beta-lactamase positive)
  8. Moraxella catarrhalis
  9. Moraxella lacunata
  10. Pseudomonas aeruginosa
  11. Staphylococcus aureus (MSSA)
  12. Staphylococcus epidermidis
  13. Staphylococcus hominis
  14. Staphylococcus lugdunesis
  15. Staphylococcus warneri
  16. Streptococcus mitis
  17. Streptococcus oralis
  18. Streptococcus pneumoniae
  19. Streptococcus salivarius

Side Effects

  1. blurred vision
  2. conjunctival hyperemia
  3. headache
  4. ocular irritation
  5. ocular pain
  6. ocular pruritus
  7. superinfection

Monitoring Parameters

  • laboratory monitoring not necessary

Contraindications

  • breast-feeding
  • contact lenses
  • fungal infection
  • geriatric
  • infants
  • infection
  • neonates
  • pregnancy
  • quinolone hypersensitivity

Interactions

There are no drug interactions associated with Besifloxacin products.

Sharing is caring!

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top